Vivmark Residential
VMRK NYSE Multi-Family Residential REITs Financials FY2016βFY2025
Vivmark Residential's revenue rose 3.8% to $3.1 billion in fiscal 2025. Its net margin was 36.2%, up from 34.8% a year earlier. It paid out $1.3 billion in dividends and buybacks.
About these figures. Vivmark Residential's filings tag its rental income as its revenue from 2020. Debt is the sum of Vivmark's unsecured notes, mortgage notes, and credit line and commercial paper, as its balance sheet shows them; the long-term debt figure in its filings already includes the commercial paper, which would count it twice. Vivmark's filings from 2019 label its spending on its apartment buildings in their own way, so capital spending and free cash flow are left blank.
What Vivmark Residential does
No business description yet.
- Legal name
- Vivmark Residential
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-051433
0000906107
Revenue and margins
Vivmark Residential had $3.1B of revenue in fiscal 2025, up 3.8% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β14.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Vivmark Residential returned $1.3B to shareholders in fiscal 2025. The diluted share count fell 0.1%.
Value Vivmark Residential yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$8.2B and divides by 390.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 27.3x Β· peers 35.0x Β· sector 28.2x.
Balance sheet
Cash, debt and the ratios that show how comfortably Vivmark Residential can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $124M | $53.9M | $50.7M | $62.3M | $55.9M |
| Debt incl. finance leases | $9.0B | $8.8B | $7.5B | $8.2B | $8.2B |
| Net debt / EBITDA | 3.5x | 4.4x | 3.6x | 3.5x | 3.3x |
| Debt / equity | 0.8x | 0.8x | 0.7x | 0.7x | 0.8x |
| Interest coverage | 6.2x | 3.9x | 4.3x | 4.8x | 4.8x |
| Total assets | $21.2B | $20.2B | $20.0B | $20.8B | $20.7B |
| Total liabilities | $9.5B | $8.5B | $8.5B | $9.2B | $9.3B |
| Shareholders' equity | $11.0B | $11.2B | $11.1B | $11.0B | $11.0B |
| Net debt (β = net cash) | $8.9B | $8.7B | $7.4B | $8.1B | $8.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$4.4M
9 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Chris CarrDirector | Sold | 1,130 | $65.28 | $0.1M | Form 4 |
| Aug 21, 2026 | Sean Thomas WillsonSenior Vice President & CAO | Sold | 300 | $66.31 | $0.0M | Form 4 |
| Aug 19, 2026 | Sean Thomas WillsonSenior Vice President & CAO | Sold | 250 | $64.32 | $0.0M | Form 4 |
| Aug 18, 2026 | Charles E Mueller JrDirector | Sold | 8,000 | $63.90 | $0.5M | Form 4 |
| Aug 18, 2026 | Christopher B. HowardDirector | Sold | 8,486 | $64.00 | $0.5M | Form 4 |
| Aug 18, 2026 | Edward M SchulmanEVP, Legal Affairs | Sold | 16,595 | $64.29 | $1.1M | Form 4 |
| Aug 18, 2026 | Susan SwanezyDirector | Sold | 15,700 | $63.80 | $1.0M | Form 4 |
| Aug 17, 2026 | Michael L ManelisExecutive Vice President & COO | Sold | 7,825 | $64.31 | $0.5M | Form 4 |
| Feb 18, 2026 | Catherine CarrawayEVP & CHRO | Sold | 749 | $63.56 | $0.0M | Form 4 |
| Feb 18, 2026 | Ian KaufmanChief Accounting Officer | Sold | 909 | $63.56 | $0.1M | Form 4 |
| Feb 18, 2026 | Michael L ManelisExecutive Vice President & COO | Sold | 2,429 | $63.56 | $0.2M | Form 4 |
| Feb 10, 2026 | Michael L ManelisExecutive Vice President & COO | Sold | 5,765 | $65.13 | $0.4M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β3.5% | β2.6% | β2.5% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Vivmark Residential VMRK | $24.2B | 3.8% | β | β | 7.6% | 27.3x | β | |
| Mid-America Apartment Communities MAA | $14.0B | 0.8% | β | β | 5.7% | 36.3x | β | Compare β |
| Essex Property Trust ESS | $17.9B | 6.4% | 47.7% | β | β | 43.3x | β | Compare β |
| UDR UDR | $11.8B | 2.4% | 32.3% | β | 6.0% | 24.4x | β | Compare β |
| Camden Property Trust CPT | $10.4B | 1.9% | β | 24.5% | 6.3% | 33.8x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.4B | $2.5B | $2.6B | $2.7B | $2.6B | $2.5B | $3.1B | $2.9B | $3.0B | $3.1B |
| Operating income | $856M | $1.0B | $1.1B | $1.4B | $1.3B | $1.7B | $1.1B | $1.2B | β | β |
| Interest expense | $482M | $384M | $413M | $390M | $365M | $273M | $283M | $270M | $286M | $307M |
| Pretax income | $417M | $613M | $689M | $939M | $932M | $1.4B | $813M | $875M | $1.1B | $1.2B |
| Income tax | $1.6M | $0.5M | $0.9M | β$2.3M | $0.9M | $0.9M | $0.9M | $1.1M | $1.3M | $1.6M |
| Net income | $4.3B | $604M | $658M | $970M | $914M | $1.3B | $777M | $835M | $1.0B | $1.1B |
| Diluted EPS | $11.68 | $1.63 | $1.77 | $2.60 | $2.45 | $3.54 | $2.05 | $2.20 | $2.72 | $2.94 |
| Diluted shares | 0.38B | 0.38B | 0.38B | 0.39B | 0.39B | 0.39B | 0.39B | 0.39B | 0.39B | 0.39B |
| Cash flow | ||||||||||
| Cash from operations | $1.2B | $1.3B | $1.4B | $1.5B | $1.3B | $1.3B | $1.5B | $1.5B | $1.6B | $1.6B |
| Depreciation and amortization | $709M | $748M | $790M | $831M | $821M | $838M | $882M | $889M | $952M | $1.0B |
| Stock-based compensation | $30.5M | $25.0M | $27.1M | $24.4M | $23.2M | $27.8M | $29.5M | $31.8M | $31.3M | $32.2M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $49.1M | $38.5M | $281M |
| Dividends paid | $4.8B | $739M | $782M | $831M | $884M | $901M | $932M | $990M | $1.0B | $1.0B |
| Dividends and buybacks | $4.8B | $739M | $782M | $831M | $884M | $900M | $932M | $1.0B | $1.1B | $1.3B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $77.2M | $50.6M | $47.4M | $45.8M | $42.6M | $124M | $53.9M | $50.7M | $62.3M | $55.9M |
| Total debt | $9.0B | $8.7B | $8.8B | $9.0B | $8.0B | $9.0B | $8.8B | $7.4B | $8.1B | $8.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $68.1M | $67.1M | $66.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $20.7B | $20.6B | $20.4B | $21.2B | $20.3B | $21.2B | $20.2B | $20.0B | $20.8B | $20.7B |
| Total liabilities | $9.8B | $9.7B | $9.6B | $10.2B | $9.2B | $9.5B | $8.5B | $8.5B | $9.2B | $9.3B |
| Shareholders' equity | $10.2B | $10.2B | $10.2B | $10.3B | $10.5B | $11.0B | $11.2B | $11.1B | $11.0B | $11.0B |
| Margins | ||||||||||
| Operating margin | 35.3% | 40.7% | 43.2% | 50.2% | 51.3% | 68.0% | 36.1% | 40.4% | β | β |
| EBITDA margin | 64.5% | 70.9% | 73.9% | 81.0% | 83.2% | 102.0% | 64.6% | 71.3% | 77.8% | 80.5% |
| Net margin | 176.9% | 24.4% | 25.5% | 35.9% | 35.5% | 54.1% | 25.1% | 29.1% | 34.8% | 36.2% |
| Returns | ||||||||||
| Return on capital | 4.2% | 5.2% | 5.8% | 7.0% | 6.9% | 8.6% | 5.5% | 6.0% | 7.2% | 7.6% |
| Return on equity | 41.5% | 5.9% | 6.4% | 9.5% | 8.8% | 12.4% | 7.0% | 7.5% | 9.4% | 10.1% |
| Return on assets | 19.6% | 2.9% | 3.2% | 4.7% | 4.4% | 6.4% | 3.8% | 4.2% | 5.1% | 5.4% |
| Growth | ||||||||||
| Revenue growth | β11.6% | 1.9% | 4.3% | 4.8% | β4.8% | β4.2% | 25.6% | β7.1% | 3.7% | 3.8% |
| Net income growth | 393.3% | β85.9% | 9.0% | 47.6% | β5.9% | 45.9% | β41.7% | 7.5% | 24.0% | 8.1% |
| EPS growth | 394.9% | β86.0% | 8.6% | 46.9% | β5.8% | 44.5% | β42.1% | 7.3% | 23.6% | 8.1% |
| Share count change | 0.4% | 0.2% | 0.3% | 0.7% | β0.1% | 0.6% | 0.4% | 0.4% | β0.0% | β0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 5.7x | 4.9x | 4.6x | 4.1x | 3.7x | 3.5x | 4.4x | 3.6x | 3.5x | 3.3x |
| Debt / equity | 0.9x | 0.9x | 0.9x | 0.9x | 0.8x | 0.8x | 0.8x | 0.7x | 0.7x | 0.8x |
| Interest coverage | 1.8x | 2.6x | 2.7x | 3.5x | 3.6x | 6.2x | 3.9x | 4.3x | 4.8x | 4.8x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 1.3% | 1.0% | 1.1% | 0.9% | 0.9% | 1.1% | 1.0% | 1.1% | 1.1% | 1.0% |
| Quality scores | ||||||||||
| Accruals ratio | 14.1% | β3.2% | β3.4% | β2.3% | β1.7% | 0.4% | β3.3% | β3.5% | β2.6% | β2.5% |
Source: SEC EDGAR XBRL filings (CIK 0000906107). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.